Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system.

These p-values were subsequently adjusted using the Bonferroni correction, with a corrected p-value <0.05 indicating a highly significant association. 2.6 Time-to-onset (TTO) analysis TTO was defined as the interval between therapy initiation (START_DT) and adverse-event onset (EVENT_DT).

also in 132,142 other papers